SCHEMBL30740905

SCHEMBL30740905

COc1cc(C=O)c(C)c(Br)c1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.55
ALDH1A1 P00352 6/20 0.50
TSHR P16473 2/20 0.50
KDM4E B2RXH2 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
ERN1 O75460 4/20 0.46
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
PPARG P37231 1/20 0.42
NCOA2 Q15596 1/20 0.42
NCOA1 Q15788 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
PTPN1 P18031 1/20 0.41
MAPT P10636 2/20 0.41
PARP1 P09874 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11999809 0.86 PRKDC (0.55) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL1134649 0.85 PRKDC (0.58) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL3152057 0.85 PRKDC (0.58) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL38661111 0.83 ALDH1A1 (0.55) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL20123251 0.83 ALDH1A1 (0.55) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL20661182 0.82 PRKDC (0.55) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL2743635 0.81 PRKDC (0.58) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL12659274 0.81 PRKDC (0.58) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL11999813 0.81 ERN1 (0.61) PRKDCALDH1A1TSHRKDM4ETDP1
SCHEMBL19453679 0.79 PRKDC (0.55) PRKDCALDH1A1TSHRKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed
EP-4561975-A1 FTO INHIBITORS RPXDS Co., Ltd (CN) 2025-06-04 EP disclosed
CN-119546566-A FTO inhibitors 瑞璞鑫(苏州)生物科技有限公司 2025-02-28 CN disclosed
WO-2024022491-A1 FTO INHIBITORS RPXDS CO., LTD (CN) 2024-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 PRKDC 3355/4885ALDH1A1 1334/4885TSHR 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.